Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The most effective method to Pick the Ideal Shrewd Bed for Your Special Rest Needs - 2Steven Spielberg's 'Disclosure Day' trailer drops: What we know about the alien movie
- 3True serenity: Investigating Emotional well-being and the Advantages of Contemplation
- 44 injured in suburban Philadelphia nursing home explosion file negligence lawsuit
- 5New electric car registrations rise sharply in Germany in March
- Israel faces tough choices over haredi draft exemptions, legal expert warns
- Vote In favor of Your Number one Game Control center
- Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- Iran's stolen futures: The arrested Iranians at risk of execution by the regime
- When the moon hits your eye from your Orion ship up high, that's a 'mare'
- Haunting Giant Squid Surfaces in Japan and Devours Its Prey (Video)
- US measles cases surpass 2,000, highest in 30 years: CDC
- Journeys That could only be described as epic: Delightful Voyage Lines All over the Planet
- OpenAI launches ChatGPT Health to connect medical records, wellness apps
